| Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema (NCT05300542) | Amazentis SA | 2022-03-17 |
| Tazarotene 0.045% Lotion for Treating PIE and PIH in Subjects With Acne (NCT05704114) | Dr. Emmy Graber | 2021-02-01 |
| Skin Protectant Properties of Omeza Collagen Matrix on Damaged Skin (NCT04512274) | Omeza, LLC | 2020-06-01 |
| A Study to Gain Information How Well Dexpanthenol Derma Cream Helps the Face Skin to Recover After Cosmetic Lasering (NCT03852563) | Bayer | 2019-03-18 |
| A Study to Gain Information How Well Dexpanthenol Dermal Spray Helps the Face Skin to Recover After Cosmetic Lasering (NCT03853538) | Bayer | 2019-01-28 |
| Durapore vs. Hy-Tape to Secure The Endotracheal Tube (NCT03633877) | Tufts Medical Center | 2018-09-17 |
| Tegaderm vs. EyeGard for Eye Protection (NCT03549429) | Tufts Medical Center | 2018-06-01 |
| Effects of Phytonutrients on Vascular Health and Skin in Obese Males (NCT03496584) | University of California, Los Angeles | 2018-03-29 |
| Pilot Study of Triphala and Rubia Cordifolia on Gut Microbiome and Skin (NCT03477825) | University of California, Davis | 2018-03-12 |
| Skin Irritation Potential of MOB015B in Healthy Subjects Using a Cumulative Irritant Patch Test Design (NCT06369675) | Moberg Pharma AB | 2017-10-19 |
| An Evaluation of the Reduction in Erythema in Adult Patients With Moderate to Severe Persistent Facial Erythema Associated With Rosacea (NCT03352323) | Padagis LLC | 2017-10-18 |
| Study to Evaluate the Sensitizing Potential of MOB015B in Healthy Subjects Using a Repeat Insult Patch Test Design (NCT06369727) | Moberg Pharma AB | 2017-10-15 |
| Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer (NCT02876107) | M.D. Anderson Cancer Center | 2016-10-06 |
| Multiday Beach Study (NCT03041064) | Johnson & Johnson Consumer and Personal Products Worldwide | 2016-05-27 |
| Effect of Thoracic Spine Mobilization on Sympathetic Nervous Systems (NCT02832141) | Bern University of Applied Sciences | 2016-05-01 |
| A Single-Center, Clinical Study to Evaluate the Safety of a New Personal Lubricant in Healthy Female Subjects (NCT02737852) | Church & Dwight Company, Inc. | 2016-03-01 |
| Human Repeat Insult Patch Test to Evaluate Personal Lubricants (NCT02737631) | Church & Dwight Company, Inc. | 2016-02-01 |
| Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy (NCT02411656) | M.D. Anderson Cancer Center | 2015-06-11 |
| A Pilot Study of Warm and Cold Compress to Reduce Injection Site Erythema Due to Peginterferon-beta-1a in MS (NCT02490943) | Brown, Theodore R., M.D., MPH | 2015-06-01 |
| A Single-Center, Clinical Study to Evaluate the Safety of a Non-Fragranced Personal Lubricant in Healthy Female Subjects (NCT02320227) | Church & Dwight Company, Inc. | 2014-12-01 |
| A Single-Center, Clinical Study to Evaluate the Safety of a Fragranced Personal Lubricant in Healthy Female Subjects (NCT02320214) | Church & Dwight Company, Inc. | 2014-12-01 |
| Repeated Insult Patch Test of Personal Lubricants (NCT02297841) | Church & Dwight Company, Inc. | 2014-11-01 |
| Safety and Efficacy of Oxymetazoline HCl Cream 1.0% in Patients With Persistent Erythema Associated With Rosacea (NCT02132117) | Allergan | 2014-06-01 |
| Efficacy and Safety of AGN-199201 in Patients With Persistent Erythema Associated With Rosacea (NCT02131636) | Allergan | 2014-05-01 |
| A Long-Term Safety and Efficacy Study AGN-19920 in Patients With Persistent Erythema Associated With Rosacea (NCT02095158) | Allergan | 2014-04-01 |
| Patient-Reported Outcome Of Facial Erythema (PROOF) (NCT01885000) | Galderma R&D | 2013-07-01 |
| AGN-199201 for the Treatment of Erythema With Rosacea (NCT01735201) | Allergan | 2012-12-01 |
| Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea (NCT01659853) | Galderma R&D | 2012-09-01 |
| A DB Randomized Study of R1 and R2 WaterJel / AloeVera Jell in Prevention of Radiation Dermatitis in Breast Cancer (NCT01597921) | Water-Jel | 2012-05-01 |
| Study of Inter- and Intra-rater Reliability of the Clinician Erythema Assessment Scale (NCT01636765) | Allergan | 2012-05-01 |
| Safety and Tolerability of AGN-199201 in Patients With Erythema Associated With Rosacea (NCT01579084) | Allergan | 2012-04-01 |
| Safety and Feasibility of Prima-Temp Thermometer Patch (NCT01587014) | Poudre Valley Health System | 2012-02-01 |
| Ultra Violet B Radiation (UVR) Study of Strontium Chloride Hexahydrate Hydrocortisone (NCT01301677) | X-pert Med GmbH | 2011-01-01 |
| Melanin Index in Those With Fitzpatrick Skin Phototypes I-VI (NCT01124513) | Northwestern University | 2010-05-01 |
| Compression Treatment of Superficial Vein Thrombosis (NCT01976637) | Medical University of Vienna | 2009-12-01 |
| Affect of Dose Rate on UVR Induced Skin Erythema (NCT00785187) | Goldenhersh, Michael, M.D. | 2008-12-01 |
| Efficacy of Dexpanthenol in Thermic Erythema (NCT00839462) | Bayer | 2007-09-01 |
| Ultraviolet Exposure, Antioxidant Use and Skin Erythema at Extreme High Altitude (NCT00685438) | Sunnybrook Health Sciences Centre | 2007-04-01 |
| Pulsed Dye Laser and Intense Pulsed Light (IPL) for the Treatment of Telangiectasia and Skin Redness (NCT00206921) | Bispebjerg Hospital | 2005-02-01 |
| Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Persistent Facial Erythema (NCT01882712) | Galderma R&D | |